China’s reopening, combined with a slew of pro-consumption policy stimuli, will likely boost household consumption by 10% in nominal terms in 2023 from a year ago. Some of the hardest hit service sectors during the pandemic will experience a strong recovery. Within the A-share market, investors shou...
The Global Equity Score did not change significantly this month and remains bearish, however on the heels of positive momentum, the sector model is now neutral-to-bullish on most growth sectors....
As the Fed meets today, we explain what it did wrong in 1970, 1974, and 1980 that prevented inflation from being exorcised, and the lessons for 2023-24. Plus, we identify a currency cross that could rebound in the next year....
MacroQuant is bearish on equities, overweight bonds, and overweight cash. Within equities, the model favors Europe over the US and is underweight on EM....
The risk-reward of the US dollar is currently positive. If a US recession is not imminent, then US bond yields will move higher, thus supporting the greenback. If the US enters a recession soon, the US dollar will benefit because it is counter-cyclical. Besides, the US dollar has not been as weak as...
Drug development is a challenging business. Yet, the market is growing, and areas such as oncology and obesity present tremendous long-term opportunities. AI will accelerate drug development and reduce its costs. From a macroeconomic standpoint, Pharma tends to outperform the market when economic gr...
Pent-up demand for services is keeping the global economy going, but we still expect recession over the next 12 months. Investors should keep a cautious portfolio stance....
